Medical Health & Life Science Research News

New study: 20.1% CAGR for stem cell assay market to 2023 - projected to reach US$ 1,978.7 million in 4 years

Medical Market Research

Stem cell assay market is dominated by North America, followed by Europe. North America will continue to dominate global stem cell assay market in forecast period. Moreover, this region is also expected to witness highest CAGR during forecast period. North America’s large share and growth can be attributed to the favorable regulatory guidelines in region, growing awareness about stem cell assays, the presence of a large number of market players, and increasing government investments in the field.

- Advertising -

Download Brochure of Stem Cell Assay Market spread across 224 Pages, Profiling 13 Companies and Supported with 188 Tables and 41 Figures is now available at www.rnrmarketresearch.com/contacts…mple?rname=714875 .

The global stem cell assay market expected to reach USD 1,978.7 Million by 2023 from USD 791.9 Million in 2018, at a CAGR of 20.1%. Market growth is primarily driven by increasing government and private funding for stem cell research and technological innovations in stem cell research-based instruments.

Stem cell assay market segmented by type, cell type, product & service, application, end user, and region.

- Advertising -

Target Audience for this Report:

  • Manufacturers and vendors of stem cell assays
  • Research associations involved in stem cell research
  • Various research and consulting firms
  • Distributors of stem cell assays
  • Contract research manufacturers of stem cell assays
  • Healthcare institutions
  • Research institutes

The key players in the stem cell assay market include Merck (Germany), Thermo Fisher Scientific (US), GE Healthcare (US), Agilent Technologies (US), Bio-Rad Laboratories (US), Promega Corporation (US), Cell Biolabs (US), PerkinElmer (US), Miltenyi Biotec (Germany), HemoGenix (US), Bio-Techne Corporation (US), STEMCELL Technologies (Canada), and Cellular Dynamics International (US).

Click Here for More Information on Stem Cell Assay Market with Forecast and Company Profiles at www.rnrmarketresearch.com/contacts…ying?rname=714875 .

Stem cell assay market is segmented by type, cell type, product & service, application, end user, and region. By type, market is segmented into viability/cytotoxicity, isolation & purification, cell identification, proliferation, differentiation, function, & apoptosis assays.

Viability/cytotoxicity segment accounted for largest market share of global stem cell assay market in 2017. Factors driving the growth of this segment include widespread use of viability/cytotoxicity assays in stem cell research activities.

Key Target Audience for this Report:

  • Manufacturers and vendors of stem cell assays
  • Research associations involved in stem cell research
  • Various research and consulting firms
  • Distributors of stem cell assays
  • Contract research manufacturers of stem cell assays
  • Healthcare institutions
  • Research institutes

The stem cell assay market classified into regenerative medicine & therapy development; drug discovery and development; and clinical research. Regenerative medicine & therapy development segment is estimated to account for the largest share of global stem cell assay market in next five years.

Large share of this segment can be attributed to growing regenerative medicine industry and increasing demand for stem cells in the development of various types of cell therapies.

Connect for More Details for More Information “Stem Cell Assay Market by Type (Viability, Purification, Identification), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instruments, Kits), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2023” report @ www.rnrmarketresearch.com/contacts…hase?rname=714875 .

Global stem cell assay market is dominated by North America, followed by Europe. North America will continue to dominate global stem cell assay market in forecast period.

Moreover, this region is also expected to witness highest CAGR during forecast period. North America’s large share & growth can be attributed to favorable regulatory guidelines in region, growing awareness about stem cell assays, presence of a large number of market players, & increasing government investments in field.

The objectives of this study are as follows:

  • To define, describe, segment, and forecast the stem cell assays market by type, cell type, product & service, application, end user, and region
  • To forecast the revenue of the market segments of North America, Europe, Asia Pacific, and the Rest of the World (RoW)
  • To identify the micromarkets with respect to drivers, restraints, industry-specific challenges, and opportunities affecting market growth
  • To strategically analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To profile the key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
  • To track and analyze competitive developments such as partnerships, agreements, collaborations, and joint ventures; mergers and acquisitions; product launches; and research and development activities in the stem cell assays market.

News From

RnR Market Research - Market Research and Competitive Analysis ReportsRnR Market Research
Category: Market Research Publishers and RetailersCompany about: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
This email address is being protected from spambots. You need JavaScript enabled to view it.